Initially, the results from the Oncomine database showed that HMGB1/2/3 were significantly highly expressed in a total of 22, 22, and 51 datasets, whereas they were lowly expressed in two, three, and one datasets of various cancers, respectively, compared with paired normal controls (Figure 1A). Here, HMGB1 is linked to cancer.